Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact map@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Ubiome Gut EXPLORER : 10% OFF
Join/Watch the weekly
TMAU UP Podcasts

Videos : TMAU stories

Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect
BannerFans.com
RESEARCH DETAILS

DONATIONS THRU 31-NOV-2016:
£ 943.03/GBP
$ 568.00/USD

TOTAL at today's ROE
£0.80/GBP = $1.00/USD

£1,398.07 = $1,745.14

MEBO UK PAYPAL FOR TRINZYME

********
MEBO US PAYPAL FOR TRINZYME

Your currency will be automatically converted to USD or GBP by PayPal.

Option: pay with your credit card instead of PayPal account by clicking on either Donate button above.

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

Friday, October 26, 2018

TMA producing bacteria 2009 thru 2017



Back in 2009, MEBO interviewed Nigel Manning, formerly the Principal Clinical Scientists, Dept. Clinical Chemistry Sheffield Children's Hospital (now retired) in which he told us that the TMA producing bacteria in the human gut had yet to be identified (that was 9 years ago). However, since the fishing industry is so lucrative, more research had been carried out into identifying TMA producing bacteria in fish, as opposed to humans, in order to determine how fresh the fish are to determine their market value. TMA is a chemical produced by bacteria in decomposing fish.

A more recent 2017 study (Rath et al. Microbiome (2017) 5:54, DOI 10.1 186/s40168-017-0271-9), "Uncovering the trimethylamine-producing bacteria of the human gut microbiota" developed a "diagnostic framework that enabled the quantification and comprehensive characterization of the TMA-producing potential in human fecal samples"

We now look forward to Proctor & Gamble marketing Dr. Hazen's new class of compounds that inhibits TMA=production by gut bacteria.
Unlike antibiotics, which non-specifically kill gut bacteria and can lead to adverse side effects and resistance, the new class of compounds prevents microbes from making a harmful molecule linked to heart disease without killing the microbes, which are part of the gut flora and may be beneficial to overall health......Because the compounds are structurally similar to choline (called analogues), the bacterial cells are “tricked” into taking them up as nutrients...

To our knowledge, this is the most potent therapy to date for ‘drugging’ the microbiome to alter a disease process. In addition, gut bacteria are altered but not killed by this drug, and there were no observable toxic side effects,” said Dr. Hazen. “The approach developed could potentially be used to target other gut microbial pathways. We look forward to advancing this novel therapeutic strategy into humans.”
https://newsroom.clevelandclinic.org/2018/08/06/potential-new-class-of-drugs-developed-at-cleveland-clinic-may-reduce-cardiovascular-risk-by-targeting-gut-microbes/

Even though Dr. Hazen's compound was research to prevent cardiovascular disease, the fact that it inhibits gut bacteria from producing TMA from choline would be a perfect way for sufferers of TMAU to be able to eat a healthy diet meeting the Adequate Intake (AI) for Choline as recommended in 1998 by the Food and Nutrition Board of the Institute of Medicine without gut bacteria converting choline into TMA, while still keeping TMA production down to an odorless level.



María

María de la Torre
Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.com
www.meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)


SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.

get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

0 comments:

Post a Comment